Podcasts hosted by Professors Thomas Powles and Brian Rini that highlight the latest developments in GU cancers. Each podcast features a guest expert from around the world discussing the latest data, debates and manuscripts relevant to the practical clinical care of GU oncology patients.
Dr. Brian Rini’s Disclosures:
- Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Taris, Seattle Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics, Merck, Surface Oncology, Dragonfly Therapeutics, Aravive, Exelixis
- Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Compugen, Merck, Corvus, Surface Oncology, 3DMedicines, Aravive, Alkermes, Arrowhead, GSK, Shionogi, Eisai
- Stock: PTC therapeutics